FAMOTIDINE Side Effects

5815153-8 | Dermatitis Exfoliative
on Jul 10, 2008 Male patient from JAPAN , 79 years of age, weighting 138.9 lb, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative. Famotidine dosage: Unk. During the same period patient was treated with MYONAL (Unk) (View Myonal Review and Myonal Label ), PLAVIX (View Plavix Review and Plavix Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ).

5792884-X | Acute Myocardial Infarction, Anorexia, Dehydration, Nausea
Patient was taking Famotidine (View Usage). Patient had the following side effects: acute myocardial infarction, anorexia, dehydration, nausea (What is nausea?) on Jun 02, 2008 from UNITED STATES Additional patient health information: Male patient , 86 years of age, . Famotidine dosage: 40 Mg;daily. During the same period patient was treated with FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), FUROSEMIDE (20 Mg;3 Times Per Week;) (View Furosemide Review and Furosemide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized.

5792003-X | Dermatitis Exfoliative
Adverse event was reported on Jun 17, 2008 by a Male patient taking Famotidine (View Usage) (Dosage: Unk) . Location: JAPAN , 79 years of age, weighting 138.9 lb, After Famotidine was administered, patient had the following side effects: dermatitis exfoliative. During the same period patient was treated with MYONAL (Unk) (View Myonal Review and Myonal Label ), PLAVIX (View Plavix Review and Plavix Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ).

5779153-9 | Acute Myocardial Infarction, Anorexia, Dehydration, Impaired Gastric Emptying, Nausea
on Jun 02, 2008 Male patient from UNITED STATES , 86 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anorexia, dehydration, impaired gastric emptying, nausea (What is nausea?). Famotidine dosage: 40 Mg; Daily. During the same period patient was treated with FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), FUROSEMIDE (20 Mg; 3 Times Per Week;) (View Furosemide Review and Furosemide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPRATROPIUM BROMIDE INHALATION SOLUTION (View Ipratropium Bromide Inhalation Solution Review and Ipratropium Bromide Inhalation Solution Label ), ISOSORBIDE MONONITRATE (15 Mg; Daily) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), METOCLOPRAMIDE (10 Mg; 4 Times A Day) (View Metoclopramide Review and Metoclopramide Label ), SERTRALINE (75 Mg; Daily) (View Sertraline Review and Sertraline Label ), NITROGLYCERIN (.4 Mg; Sublingual) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.


5778753-X | Aphthous Stomatitis, Oral Candidiasis
on Jun 18, 2008 Female patient from UNITED STATES , 20 years of age, weighting 302.0 lb, was diagnosed with prophylaxis against gastrointestinal ulcer and was treated with Famotidine (View Usage). Patient had the following side effects: aphthous stomatitis, oral candidiasis. Famotidine dosage: 20mg Bid Po. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRENANTAL MVI NUTRINATE (View Prenantal Mvi -nutrinate- Review and Prenantal Mvi -nutrinate- Label ), LORTAB (View Lortab Review and Lortab Label ).

5778008-3 | Anorexia, Dehydration, Nausea
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: anorexia, dehydration, nausea (What is nausea?) on Jun 03, 2008 from UNITED STATES Additional patient health information: Male patient , 86 years of age, . Famotidine dosage: 40 Mg; Daily. During the same period patient was treated with FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), FUROSEMIDE (20 Mg; 3 Times Per Week;) (View Furosemide Review and Furosemide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPARTROPIUM BROMIDE INHALATION SOLUTION (View Ipartropium Bromide Inhalation Solution Review and Ipartropium Bromide Inhalation Solution Label ), ISOSORBIDE MONONITRATE (15 Mg; Daily;) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), METOCLOPRAMIDE (10 Mg; 4 Times A Day;) (View Metoclopramide Review and Metoclopramide Label ), SERTRALINE (75 Mg; Daily;) (View Sertraline Review and Sertraline Label ), NITROGLYCERIN (.4 Mg; Sublingual) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5702830-2 | Thrombocytopenia
Adverse event was reported on Apr 10, 2008 by a Male patient taking Famotidine (View Usage) (Dosage: ) . Location: UNITED STATES , 87 years of age, Patient experienced the following unwanted or unexpected effects: thrombocytopenia.

5690073-0 | Deafness Bilateral
on Mar 24, 2008 Female patient from JAPAN , 70 years of age, was diagnosed with onychomycosis and was treated with Famotidine (View Usage). Patient had the following side effects: deafness bilateral. Famotidine dosage: 20 Mg. During the same period patient was treated with ULCERLMIN (3 G) (View Ulcerlmin Review and Ulcerlmin Label ), RIZE (5 Mg) (View Rize Review and Rize Label ), ASTAT (View Astat Review and Astat Label ), SUNRYTHM (View Sunrythm Review and Sunrythm Label ), LAMISIL (Unk, Unk) (View Lamisil Review and Lamisil Label ).

5635800-3 | Abdominal Distension, Acidosis, Apnoea, Blood Creatine Increased, Cardiogenic Shock, Clostridium Difficile Colitis, Crepitations, Dehydration, Dyspnoea
on Feb 05, 2008 Female patient from BULGARIA , 77 years of age, was diagnosed with clostridial infection, cholecystitis and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: abdominal distension, acidosis, apnoea, blood creatine increased, cardiogenic shock, clostridium difficile colitis, crepitations, dehydration, dyspnoea. Famotidine dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CEFAMANDOLE (View Cefamandole Review and Cefamandole Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

5605161-4 | Completed Suicide, Poisoning
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, poisoning (What is poisoning?) on Jan 07, 2008 from UNITED STATES Additional patient health information: Male patient , 43 years of age, . Famotidine dosage: (df Oral). During the same period patient was treated with ACETAMINOPHEN ((df Oral)) (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN ((df Oral)) (View Ibuprofen Review and Ibuprofen Label ), DIPHENHYDRAMINE HCL ((df Oral)) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5605158-4 | Poisoning
Adverse event was reported on Jan 07, 2008 by a Female patient taking Famotidine (View Usage) (Dosage: (df Oral)) . Location: UNITED STATES , 64 years of age, Patient had the following side effects: poisoning (What is poisoning?). During the same period patient was treated with QUETIAPINE FUMARATE ((df Oral)) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), VENLAFAXINE HCL ((df Oral)) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), DIPHENHYDRAMINE HCL ((df Oral)) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5589928-7 | Overdose
on Dec 31, 2007 Female patient from UNITED STATES , 64 years of age, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: overdose. Famotidine dosage: . During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

5586964-1 | Completed Suicide
on Dec 31, 2007 Male patient from UNITED STATES , 43 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Famotidine dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), DIPHENYDRAMINE HCL (View Diphenydramine Hcl Review and Diphenydramine Hcl Label ).

5573097-3 | Clostridium Difficile Colitis
Patient was taking Famotidine (View Usage). Patient had the following side effects: clostridium difficile colitis on Dec 03, 2007 from BULGARIA Additional patient health information: Female patient , 77 years of age, was diagnosed with clostridial infection, cholecystitis and. Famotidine dosage: . During the same period patient was treated with AMINOGLYCOSIDES (View Aminoglycosides Review and Aminoglycosides Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

5566699-1 | Thrombocytopenic Purpura
Adverse event was reported on Dec 11, 2007 by a Male patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with gastric ulcer and. Location: JAPAN , 66 years of age, After Famotidine was administered, patient had the following side effects: thrombocytopenic purpura. During the same period patient was treated with UFT (View Uft Review and Uft Label ). Patient was hospitalized.

5528489-5 | Pyelonephritis
on Nov 20, 2007 Male patient from JAPAN , 41 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: pyelonephritis. Famotidine dosage: . During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), MEILAX (View Meilax Review and Meilax Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ).

5524135-5 | Liver Disorder
on Nov 15, 2007 Female patient from JAPAN , 65 years of age, was diagnosed with gastritis prophylaxis, hepatitis c (What is hepatitis c?), diabetes mellitus and was treated with Famotidine (View Usage). Patient had the following side effects: liver disorder. Famotidine dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), ADALAT (View Adalat Review and Adalat Label ), INNOLET R (View Innolet R Review and Innolet R Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5507095-2 | Liver Disorder
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: liver disorder on Oct 30, 2007 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with pancreatitis, diabetes mellitus and. Famotidine dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), ADALAT (View Adalat Review and Adalat Label ), INNOLET R (View Innolet R Review and Innolet R Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5499650-3 | International Normalised Ratio Increased, Pyrexia, Renal Impairment
Adverse event was reported on Oct 17, 2007 by a Male patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with gastric ulcer, depression (What is depression?), hypertension, nocturia, cerebral infarction, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, pyrexia, renal impairment. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), VESICARE (View Vesicare Review and Vesicare Label ), BLOPRESS (View Blopress Review and Blopress Label ), PLAVIX (View Plavix Review and Plavix Label ), NORVASC (View Norvasc Review and Norvasc Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.

5487310-4 | Electrocardiogram Qt Prolonged
on Sep 20, 2007 Female patient from JAPAN , 70 years of age, was treated with Famotidine (View Usage). Patient had the following side effects: electrocardiogram qt prolonged. Famotidine dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), OLMETEC (View Olmetec Review and Olmetec Label ), DIART (View Diart Review and Diart Label ).

5486314-5 | Acute Myocardial Infarction
on Oct 04, 2007 Female patient from BRAZIL , 73 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: acute myocardial infarction. Famotidine dosage: . During the same period patient was treated with NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), ZELNORM (12 Mg, Bid) (View Zelnorm Review and Zelnorm Label ). Patient was hospitalized.

5483273-6 | Acute Myocardial Infarction
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction on Oct 04, 2007 from BRAZIL Additional patient health information: Female patient , 73 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Famotidine dosage: . During the same period patient was treated with NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), ZELNORM (12 Mg, Bid) (View Zelnorm Review and Zelnorm Label ).

5478527-3 | International Normalised Ratio Increased, Pyrexia, Renal Impairment
Adverse event was reported on Sep 26, 2007 by a Male patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with gastric ulcer, depression (What is depression?), hypertension, nocturia, cerebral infarction, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , weighting 123.5 lb, Patient had the following side effects: international normalised ratio increased, pyrexia, renal impairment. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), VESICARE (View Vesicare Review and Vesicare Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), PLAVIX (View Plavix Review and Plavix Label ), NORVASC (View Norvasc Review and Norvasc Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.

5470565-X | Failure To Thrive, Hypogammaglobulinaemia, Rash, Vomiting
on Sep 19, 2007 Female patient from JAPAN , child 6 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: failure to thrive, hypogammaglobulinaemia, rash (What is rash?), vomiting. Famotidine dosage: 10 Mg/d. During the same period patient was treated with GLEEVEC (300 Mg/d) (View Gleevec Review and Gleevec Label ).

5466635-2 | Abdominal Discomfort
on Sep 21, 2007 Female patient from UNITED STATES , 60 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort. Famotidine dosage: .

5409878-6 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Diarrhoea, Enanthema, Erythema, Gamma-glutamyltransferase Increased, Mucosal Erosion
Patient was taking Famotidine (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, enanthema, erythema, gamma-glutamyltransferase increased, mucosal erosion on May 09, 2007 from JAPAN Additional patient health information: Female patient , 51 years of age, weighting 198.4 lb, was diagnosed with depression (What is depression?) and. Famotidine dosage: . During the same period patient was treated with ASTOMIN (View Astomin Review and Astomin Label ), ALINAMIN (View Alinamin Review and Alinamin Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), CALBLOCK (View Calblock Review and Calblock Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), TEGRETOL (100 Mg/day) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5409809-9 | Electrocardiogram Qt Prolonged
Adverse event was reported on Jul 31, 2007 by a Female patient taking Famotidine (View Usage) (Dosage: ) . Location: JAPAN , 70 years of age, After Famotidine was administered, patient had the following side effects: electrocardiogram qt prolonged. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OLMETEC (View Olmetec Review and Olmetec Label ), DIART (View Diart Review and Diart Label ).

5407786-8 | Pneumonia
on Jul 24, 2007 Male patient from JAPAN , 81 years of age, was diagnosed with ventricular tachycardia and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Famotidine dosage: Unk, Unk. During the same period patient was treated with BIOFERMIN (Unk, Unk) (View Biofermin Review and Biofermin Label ), GLUCONSAN K (Unk, Unk) (View Gluconsan K Review and Gluconsan K Label ), BISOLVON (Unk, Unk) (View Bisolvon Review and Bisolvon Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

5395571-5 | Pneumonia
on Jul 10, 2007 Male patient from JAPAN , 81 years of age, was diagnosed with ventricular tachycardia and was treated with Famotidine (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Famotidine dosage: . During the same period patient was treated with BIOFERMIN (View Biofermin Review and Biofermin Label ), GLUCONSAN K (View Gluconsan K Review and Gluconsan K Label ), BISOLVON (View Bisolvon Review and Bisolvon Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

5370377-1 | Haemodynamic Instability, Platelet Count Decreased, Post Procedural Complication
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: haemodynamic instability, platelet count decreased, post procedural complication on Jun 25, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with prophylaxis, stress ulcer and. Famotidine dosage: 20mg Iv Daily. During the same period patient was treated with INTRAAORTIC BALLOON PUMP (View Intraaortic Balloon Pump Review and Intraaortic Balloon Pump Label ). Patient was hospitalized.

5346615-8 | Retinopathy, Vision Blurred
Adverse event was reported on May 21, 2007 by a Male patient taking Famotidine (View Usage) (Dosage: 20 Mg 2 Doses Po) was diagnosed with gastric ulcer and. Location: TAIWAN, PROVINCE OF CHINA , 57 years of age, Patient experienced the following unwanted or unexpected effects: retinopathy, vision blurred.

5342049-0 | Confusional State, Hallucination
on May 30, 2007 Female patient from UNITED STATES , weighting 133.4 lb, was diagnosed with prophylaxis and was treated with Famotidine (View Usage). Patient had the following side effects: confusional state, hallucination. Famotidine dosage: 20 Mg Qhs Po.

5341582-5 | Thrombocytopenia
on May 29, 2007 Male patient from UNITED STATES , 79 years of age, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: thrombocytopenia. Famotidine dosage: .

5315685-5 | Aphasia, Hypoaesthesia
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), hypoaesthesia on Apr 24, 2007 from JAPAN Additional patient health information: Female patient , 89 years of age, was diagnosed with gastritis and. Famotidine dosage: .

5290965-0 | Pharmaceutical Product Counterfeit
Adverse event was reported on Apr 05, 2007 by a Female patient taking Famotidine (View Usage) (Dosage: 20mg Qhs, Prn Po) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , 61 years of age, weighting 156.0 lb, Patient had the following side effects: pharmaceutical product counterfeit.

5272450-5 | Arthralgia, Cardiac Flutter, Gastrooesophageal Reflux Disease, Labyrinthitis, Urticaria
on Mar 07, 2007 Female patient from UNITED STATES , 69 years of age, weighting 150.0 lb, was diagnosed with gastritis, gastrooesophageal reflux disease and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: arthralgia, cardiac flutter, gastrooesophageal reflux disease, labyrinthitis, urticaria. Famotidine dosage: 20-40 Mg Per Day Po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5272334-2 | Epistaxis, Thrombocytopenia
on Mar 20, 2007 Male patient from UNITED STATES , weighting 188.9 lb, was diagnosed with stress ulcer and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, thrombocytopenia. Famotidine dosage: 20mg Q12h (iv). During the same period patient was treated with HEPARIN (Continuous Infusion) (View Heparin Review and Heparin Label ), ZOSYN (View Zosyn Review and Zosyn Label ), IAPB (View Iapb Review and Iapb Label ). Patient was hospitalized.

5236647-2 |
Patient was taking Famotidine (View Usage). on Feb 01, 2007 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Famotidine dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ).

5225799-6 | Oedema Peripheral, Rash
Adverse event was reported on Jan 30, 2007 by a Male patient taking Famotidine (View Usage) (Dosage: 1 Tablet Twice Daily Po) was diagnosed with stomach discomfort and. Location: UNITED STATES , 53 years of age, weighting 270.0 lb, After Famotidine was administered, patient had the following side effects: oedema peripheral, rash (What is rash?).

5147134-4 | Retinopathy
on Oct 25, 2006 Male patient from TAIWAN, PROVINCE OF CHINA , 57 years of age, was diagnosed with gastric ulcer and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: retinopathy. Famotidine dosage: 20 Mg 2 Doses Po.

5056082-X | Cardiac Arrest, Epistaxis, Hypertension, Myocardial Infarction, Stress
on Jul 11, 2006 Female patient from UNITED STATES , 54 years of age, weighting 183.0 lb, was treated with Famotidine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), epistaxis, hypertension, myocardial infarction, stress (What is stress?). Famotidine dosage: 20 Milligram. During the same period patient was treated with VERSED (View Versed Review and Versed Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ). Patient was hospitalized.

5050805-1 | Retinopathy, Vision Blurred, Visual Acuity Reduced
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: retinopathy, vision blurred, visual acuity reduced on Jun 23, 2006 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 57 years of age, was diagnosed with gastric ulcer and. Famotidine dosage: 20 Mg, Bid.

5037051-2 | Cardiac Arrest, Chest Pain, Epistaxis, Hypertension, Stress
Adverse event was reported on Jun 15, 2006 by a Female patient taking Famotidine (View Usage) (Dosage: 20 Milligram) . Location: UNITED STATES , 54 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), chest pain (What is chest pain?), epistaxis, hypertension, stress (What is stress?). During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ), TRIAMTERENE AND HYDROCHLOROTHIAZID HARRIS (View Triamterene And Hydrochlorothiazid Harris Review and Triamterene And Hydrochlorothiazid Harris Label ).

5024007-9 | Cardiac Arrest, Epistaxis, Hypertension, Myocardial Infarction
on May 30, 2006 Female patient from UNITED STATES , 54 years of age, was treated with Famotidine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), epistaxis, hypertension, myocardial infarction. Famotidine dosage: 20 Milligram. During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ), TRIAMTERENE AND HYDROCHLORTHIAZID ^HARRIS^ (View Triamterene And Hydrochlorthiazid ^harris^ Review and Triamterene And Hydrochlorthiazid ^harris^ Label ).

5012365-0 | Leukopenia
on May 25, 2006 Male patient from UNITED STATES , 45 years of age, was diagnosed with hyperchlorhydria and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: leukopenia. Famotidine dosage: 20mg Bid Po.

4996165-3 | Retinopathy
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: retinopathy on Apr 25, 2006 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 57 years of age, was diagnosed with gastric ulcer and. Famotidine dosage: 20 Mg Bid X 2 Oral.

4987770-9 | No Therapeutic Response
Adverse event was reported on Apr 28, 2006 by a Female patient taking Famotidine (View Usage) (Dosage: 40 Mg Po Qd) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 216.0 lb, Patient had the following side effects: no therapeutic response. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4973326-0 | Abdominal Pain, Cerebrovascular Accident, Hypertension, Presenile Dementia, Psychiatric Symptom
on Jul 06, 2005 Female patient from UNITED STATES , 59 years of age, weighting 149.9 lb, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cerebrovascular accident, hypertension, presenile dementia, psychiatric symptom. Famotidine dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), ULTRAM (View Ultram Review and Ultram Label ), ACTOS (View Actos Review and Actos Label ), AMARYL (View Amaryl Review and Amaryl Label ), MYSOLINE (View Mysoline Review and Mysoline Label ), SIMETHICONE (View Simethicone Review and Simethicone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

4948563-1 | Deafness
on Mar 13, 2006 Female patient from JAPAN , 55 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Famotidine dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ZOCOR (View Zocor Review and Zocor Label ).

4927628-4 | Angina Pectoris, Angina Unstable, Arthropathy, Blood Cholesterol Increased, Cardiac Disorder, Cardiovascular Disorder, Chest Pain, Coronary Artery Disease, Coronary Artery Stenosis
Patient was taking Famotidine (View Usage). Patient had the following side effects: angina pectoris, angina unstable, arthropathy, blood cholesterol increased, cardiac disorder, cardiovascular disorder, chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?), coronary artery stenosis on Oct 11, 2005 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 205.0 lb, was diagnosed with gastrooesophageal reflux disease, chest pain (What is chest pain?), arthritis (What is arthritis?), gout (What is gout?), blood cholesterol and. Famotidine dosage: . During the same period patient was treated with NITROQUICK (View Nitroquick Review and Nitroquick Label ), VIOXX (View Vioxx Review and Vioxx Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized and became disabled.